|
|
Post by dayanand33 on Nov 10, 2014 17:34:56 GMT
seekingalpha.com/article/2664545-stemcells-inc-faces-tough-times-aheadI am increasingly growing suspicious about the intent behind sa articles. Most of the content in the article is old and dated. The author has no new perspective and is merely bashing the stock. I won't be surprised if this article was written sometime in August and he decided to get it published now to pull down the stock. PS: I am not invested in STEM as I don't see any near term catalyst.
|
|
|
|
Post by CM kipper007 on Nov 10, 2014 17:45:02 GMT
seekingalpha.com/article/2664545-stemcells-inc-faces-tough-times-aheadI am increasingly growing suspicious about the intent behind sa articles. Most of the content in the article is old and dated. The author has no new perspective and is merely bashing the stock. I won't be surprised if this article was written sometime in August and he decided to get it published now to pull down the stock. PS: I am not invested in STEM as I don't see any near term catalyst. They company has an open day on the 20th of November. Not making any accusations, but just saying, wouldn't it be optimal as a short-term investing point of view to knock the stock then sell it on the event of any news on the 20th? |
|
|
|
Post by Whidbeygal CM 20/20 on Nov 10, 2014 21:01:27 GMT
I,personally, put more credibility in an article written by a chemical engineer (the 'kind of ultimate' biochemist) that has ten years experience with FDA , a genuine name (no alias) and a cute smile on top of all that (an actual photo of himself) than I do the author of the former articles. Pure and simple. Do I agree with everything he wrote ? No. But I can have my own opinion but not make up my own facts----and that is what the former articles (JMY Investments) did. Tried to make his opinions appear to be 'facts'. I held STEM THROUGH MANY YEARS (even through a reverse split a few years ago). I sold earlier in the year.
|
|
|
|
Post by jckrdu on Nov 11, 2014 21:35:51 GMT
seekingalpha.com/article/2664545-stemcells-inc-faces-tough-times-aheadI am increasingly growing suspicious about the intent behind sa articles. Most of the content in the article is old and dated. The author has no new perspective and is merely bashing the stock. I won't be surprised if this article was written sometime in August and he decided to get it published now to pull down the stock. PS: I am not invested in STEM as I don't see any near term catalyst. They company has an open day on the 20th of November. Not making any accusations, but just saying, wouldn't it be optimal as a short-term investing point of view to knock the stock then sell it on the event of any news on the 20th? Day / Kip - There is a near term catalyst out there as Day posted. Per their Nov 3rd PR, new data will be provided on or before Nov 20th on the AMD and spinal cord trials. Not sure exactly what will be shared, but they've been talking about this "investor event" since last summer... so I imagine they'll release some additional positive data and put on a show. ___________________________ "Our Company has begun the transformation from small, uncontrolled Phase I clinical trials to controlled, Phase II proof of concept studies for dry age-related macular degeneration (AMD) and cervical spinal cord injury. I am very excited to host our inaugural investor and analyst event which will allow us to showcase our unique technology, provide an update on our clinical progress and lay out our plans for the next phase of clinical development," said Martin McGlynn, president and CEO of StemCells, Inc. "We continue to gain insight into the capabilities of our proprietary HuCNS-SC cellular platform through both preclinical research and clinical trials and we will be providing new data on both fronts. A key feature of the event is to allow broad access to the conference via webcast, and web based participants will be able to interact in the question and answer session."
finance.yahoo.com/news/stemcells-inc-host-inaugural-investor-222527653.html |
|
|
|
Post by jckrdu on Nov 11, 2014 21:40:31 GMT
They company has an open day on the 20th of November. Not making any accusations, but just saying, wouldn't it be optimal as a short-term investing point of view to knock the stock then sell it on the event of any news on the 20th? Day / Kip - There is a near term catalyst out there as Day posted. Per their Nov 3rd PR, new data will be provided on or before Nov 20th on the AMD and spinal cord trials. Not sure exactly what will be shared, but they've been talking about this "investor event" since last summer... so I imagine they'll release some additional positive data and put on a show. ___________________________ "Our Company has begun the transformation from small, uncontrolled Phase I clinical trials to controlled, Phase II proof of concept studies for dry age-related macular degeneration (AMD) and cervical spinal cord injury. I am very excited to host our inaugural investor and analyst event which will allow us to showcase our unique technology, provide an update on our clinical progress and lay out our plans for the next phase of clinical development," said Martin McGlynn, president and CEO of StemCells, Inc. "We continue to gain insight into the capabilities of our proprietary HuCNS-SC cellular platform through both preclinical research and clinical trials and we will be providing new data on both fronts. A key feature of the event is to allow broad access to the conference via webcast, and web based participants will be able to interact in the question and answer session."
finance.yahoo.com/news/stemcells-inc-host-inaugural-investor-222527653.htmlAfter reading the bolded above again, it looks like they're going to provide new data on both preclinical research and clinical trials. So, I interpret that to mean we'll get at least some new data on at least 1 of the on-going clinical trials. |
|
